BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 24951259)

  • 1. Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer.
    Yu J; Wu WK; Li X; He J; Li XX; Ng SS; Yu C; Gao Z; Yang J; Li M; Wang Q; Liang Q; Pan Y; Tong JH; To KF; Wong N; Zhang N; Chen J; Lu Y; Lai PB; Chan FK; Li Y; Kung HF; Yang H; Wang J; Sung JJ
    Gut; 2015 Apr; 64(4):636-45. PubMed ID: 24951259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis.
    Zhuang Y; Wang H; Jiang D; Li Y; Feng L; Tian C; Pu M; Wang X; Zhang J; Hu Y; Liu P
    BMC Cancer; 2021 Apr; 21(1):380. PubMed ID: 33836681
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Siraj AK; Masoodi T; Bu R; Pratheeshkumar P; Al-Sanea N; Ashari LH; Abduljabbar A; Alhomoud S; Al-Dayel F; Alkuraya FS; Al-Kuraya KS
    Gut; 2018 Apr; 67(4):663-671. PubMed ID: 28183795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Aberrant Alteration of Genome in Colorectal Cancer by Exome Sequencing.
    Liang Y; Jiang L; Zhong X; Hochwald SN; Wang Y; Huang L; Nie Q; Huang H; Xu JF
    Am J Med Sci; 2019 Nov; 358(5):340-349. PubMed ID: 31445671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole Exome Sequencing of Ulcerative Colitis-associated Colorectal Cancer Based on Novel Somatic Mutations Identified in Chinese Patients.
    Yan P; Wang Y; Meng X; Yang H; Liu Z; Qian J; Zhou W; Li J
    Inflamm Bowel Dis; 2019 Jul; 25(8):1293-1301. PubMed ID: 30794281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance validation of an amplicon-based targeted next-generation sequencing assay and mutation profiling of 648 Chinese colorectal cancer patients.
    Wang Y; Liu H; Hou Y; Zhou X; Liang L; Zhang Z; Shi H; Xu S; Hu P; Zheng Z; Liu R; Tang T; Ye F; Liang Z; Bu H
    Virchows Arch; 2018 Jun; 472(6):959-968. PubMed ID: 29705968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel 4-gene prognostic signature for hypermutated colorectal cancer.
    Ge W; Cai W; Bai R; Hu W; Wu D; Zheng S; Hu H
    Cancer Manag Res; 2019; 11():1985-1996. PubMed ID: 30881123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
    Kovaleva V; Geissler AL; Lutz L; Fritsch R; Makowiec F; Wiesemann S; Hopt UT; Passlick B; Werner M; Lassmann S
    Mol Cancer; 2016 Oct; 15(1):63. PubMed ID: 27756406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer.
    Mehrvarz Sarshekeh A; Advani S; Overman MJ; Manyam G; Kee BK; Fogelman DR; Dasari A; Raghav K; Vilar E; Manuel S; Shureiqi I; Wolff RA; Patel KP; Luthra R; Shaw K; Eng C; Maru DM; Routbort MJ; Meric-Bernstam F; Kopetz S
    PLoS One; 2017; 12(3):e0173345. PubMed ID: 28267766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of multiple gene detection with a 22-gene panel in formalin-fixed paraffin-embedded specimens of 207 colorectal cancer patients.
    Gao XH; Yu GY; Hong YG; Lian W; Chouhan H; Xu Y; Liu LJ; Bai CG; Zhang W
    Int J Clin Oncol; 2019 Feb; 24(2):141-152. PubMed ID: 30612269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of frequent somatic mutations detected by high-throughput targeted sequencing in archived colorectal cancer samples.
    Dallol A; Buhmeida A; Al-Ahwal MS; Al-Maghrabi J; Bajouh O; Al-Khayyat S; Alam R; Abusanad A; Turki R; Elaimi A; Alhadrami HA; Abuzenadah M; Banni H; Al-Qahtani MH; Abuzenadah AM
    J Transl Med; 2016 May; 14(1):118. PubMed ID: 27146902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Prevalence and Clinical Relevance of Genes Affected by Chromosomal Breaks in Colorectal Cancer.
    van den Broek E; Dijkstra MJ; Krijgsman O; Sie D; Haan JC; Traets JJ; van de Wiel MA; Nagtegaal ID; Punt CJ; Carvalho B; Ylstra B; Abeln S; Meijer GA; Fijneman RJ
    PLoS One; 2015; 10(9):e0138141. PubMed ID: 26375816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer risk and patients' survival: influence of polymorphisms in genes somatically mutated in colorectal tumors.
    Huhn S; Bevier M; Pardini B; Naccarati A; Vodickova L; Novotny J; Vodicka P; Hemminki K; Försti A
    Cancer Causes Control; 2014 Jun; 25(6):759-69. PubMed ID: 24706189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma.
    Parry M; Rose-Zerilli MJ; Gibson J; Ennis S; Walewska R; Forster J; Parker H; Davis Z; Gardiner A; Collins A; Oscier DG; Strefford JC
    PLoS One; 2013; 8(12):e83244. PubMed ID: 24349473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of colorectal cancer patients with tumors carrying the TP53 mutation on the codon 72 proline allele that benefited most from 5-fluorouracil (5-FU) based postoperative chemotherapy.
    Godai TI; Suda T; Sugano N; Tsuchida K; Shiozawa M; Sekiguchi H; Sekiyama A; Yoshihara M; Matsukuma S; Sakuma Y; Tsuchiya E; Kameda Y; Akaike M; Miyagi Y
    BMC Cancer; 2009 Dec; 9():420. PubMed ID: 19954513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients.
    Chen J; Guo F; Shi X; Zhang L; Zhang A; Jin H; He Y
    BMC Cancer; 2014 Nov; 14():802. PubMed ID: 25367198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The landscape of somatic mutation in sporadic Chinese colorectal cancer.
    Liu Z; Yang C; Li X; Luo W; Roy B; Xiong T; Zhang X; Yang H; Wang J; Ye Z; Chen Y; Song J; Ma S; Zhou Y; Yang M; Fang X; Du J
    Oncotarget; 2018 Jun; 9(44):27412-27422. PubMed ID: 29937994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Analysis of Genomic and Expression Data Identified Potential Markers for Predicting Prognosis and Immune Response in CRC.
    He Y; Dai X; Chen Y; Huang S
    Genet Res (Camb); 2022; 2022():1831211. PubMed ID: 35975176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC.
    Schell MJ; Yang M; Teer JK; Lo FY; Madan A; Coppola D; Monteiro AN; Nebozhyn MV; Yue B; Loboda A; Bien-Willner GA; Greenawalt DM; Yeatman TJ
    Nat Commun; 2016 Jun; 7():11743. PubMed ID: 27302369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.